Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis

Clinical trial NCT06723171 · SUSPENDED

Trial details

NCT number: NCT06723171
Sponsor: Io Therapeutics
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis Plaque Type Psorisis Plaque Psoriasis

Start date: 2026-03-01
Primary completion: 2026-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.